ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+12.05%-.--% 44,934 M€
+14.01%-.--% 35,761 M€
+8.82%-.--% 28 M€
-1.63%-.--% 33 M€
+13.41%-.--% 33 M€
+6.34%-.--% 37 M€
+1.77%-.--% 49 M€
+10.27%-.--% 66 M€
+9.62%-.--% 67 M€
+7.94%-.--% 75 M€
+4.06%-.--% 80 M€
+11.01%-.--% 122 M€
+1.51%-.--% 293 M€
+11.65%-.--% 27,154 M€
+13.94%-.--% 750 M€
+11.10%-.--% 507 M€
+3.18%-.--% 165 M€
+13.47%-.--% 148 M€
+20.81%9.51% 15 M€
+24.44%9.43% 429 M€
+23.62%9.05% 78 M€
+23.92%9.05% 1,079 M€
+22.24%8.88% 9,953 M€
+23.26%8.54% 81 M€
+15.29%4.47% 7 M€
+6.75%4.4% 28 M€
+27.36%4.33% 11 M€
+49.25%4.15% 58 M€
+39.87%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!